IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

DC Funds, LP

Q2 2025 Holdings

Filed 2025-08-14 | 3 holdings | $2.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Tscan Therapeutics Inc(TCRX)COM89854M101$913.5K630,00042.4%
Werewolf Therapeutics Inc(HOWL)COM95075A107$642.1K589,10229.8%
Barinthus Biotherapeutics PL(BRNS)ADS91864C107$597.3K642,20427.7%